Ghosh Kuntal, Baghel M S
Department of Kayachikitsa, IPGT & RA, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Ex. Director, IPGT & RA, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Ayu. 2017 Jan-Jun;38(1-2):15-23. doi: 10.4103/ayu.AYU_75_14.
is a lifestyle disorder caused due to vitiation of and by .
The objective was to assess the role of predominance in the management of .
Patients who had fulfilled the inclusion criteria were registered primarily for this study. Out of them, those who were selected only by the presence of cardinal features of were allotted randomly in Group C-1 and Group C-2 and rest of them were allotted in Group A and B after diagnosed by typical feaCharaka Samhita of Agnivesha, Chikitsa Sthana.tures of and predominant and had been treated with and granules, respectively.
Regarding overall effect of therapy, marked positive improvement in Group A was 35.29%, in Group B, 26.47%, in Group C-1, 23.08%, and Group C-2, 16.67%. No improvement was observed only in Group C-1 (4.76%) and C-2 (5.56%). Complete remission (2.56%) was observed only in Group C-2 (5.56%).
Out of 112 registered patients with a mean age of 42 years, 107 had completed their treatment. Maximum patients were male (66.96%), Hindu (83.93%), married (94.64%), middle class (43.75%), and educated (93.75%) from (96.43%) and used to take (83.04%). Patients of Group A and Group B, who were diagnosed and treated according to the predominance, showed better improvement than of Group C-1 and Group C-2 where patients were diagnosed and treated as per the cardinal features of only.
Treatment of disease according to predominance is more effective than of only cardinal features.
是一种因[具体因素1]和[具体因素2]受[具体因素3]影响而导致的生活方式紊乱疾病。
本研究旨在评估[具体因素4]优势在[疾病名称]管理中的作用。
符合纳入标准的患者首先登记参加本研究。其中，仅因具有[疾病名称]主要特征而被选中的患者被随机分配到C - 1组和C - 2组，其余患者在根据阿格尼吠舍的《恰拉卡本集》、《治疗篇》中[疾病名称]和[具体因素5]优势的典型特征诊断后，分别被分配到A组和B组，并分别接受[具体药物1]和[具体药物2]颗粒治疗。
关于治疗的总体效果，A组显著改善率为35.29%，B组为26.47%，C - 1组为23.08%，C - 2组为16.67%。仅C - 1组（4.76%）和C - 2组（5.56%）未观察到改善。仅C - 2组（5.56%）观察到完全缓解（2.56%）。
在112名登记患者中，平均年龄42岁，107名完成了治疗。大多数患者为男性（66.96%），印度教徒（83.93%），已婚（94.64%），中产阶级（43.75%），受过教育（93.75%），来自[具体地区]（96.43%），且习惯服用[具体物质]（83.04%）。根据[具体因素5]优势进行诊断和治疗的A组和B组患者，比仅根据[疾病名称]主要特征进行诊断和治疗的C - 1组和C - 2组患者改善情况更好。
根据[具体因素5]优势治疗疾病比仅依据主要特征更有效。
